Twin Helix
Distributes and supports bioprinters and laboratory instruments for life sciences research, enabling 3D cell culture and tissue engineering applications.
- CEO / Founder
- Alessandro Polini
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $58,152
- Latest Round
- Grant
Technology & Products
Key Products
CELLINK BIO X bioprinter; IVTech cell culture chambers; Logos Biosystems tissue clearing equipment; Biobanking storage and traceability solutions
Technological Advantage
Established partnerships with leading bioprinting manufacturers (e.g., CELLINK) provide early access to new technologies; proprietary services include custom software/robotic solutions and sample labeling systems for biobanking.
Differentiation
Value Proposition
Provides Italian researchers with direct access to validated bioprinting technologies and consumables, reducing procurement lead times and offering localized technical support for advanced 3D cell culture workflows.
How They Differentiate
As a specialized distributor rather than a manufacturer, Twin Helix competes on localized customer support, rapid delivery, and integration services within Italy, unlike global manufacturers that rely on broader, less personalized distribution networks.
Market & Competition
Target Customers
Academic and industrial researchers in cellular and molecular biology, biotechnology, pharmaceuticals, and agro-food sectors
Industry Verticals
Life Sciences; Biotechnology; Pharmaceutical; Agro-Food Research
Competitors
CELLINK; Allevi; REGEMAT 3D
Growth & Milestones
Growth Metrics
Partnership with BiomimX and celebration of company events — indicates strategic expansion and market presence, though no quantitative metrics provided
Major Milestones
Founded in 2006; Strategic partnership with BiomimX announced in 2024; Distribution agreement with SolidWorld Group for Electrospider bioprinters in Italy